Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Myelodysplastic Syndromes 42Leukemia, Myeloid, Acute 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia 20Lymphoma, Non-Hodgkin 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Hodgkin Disease 11Leukemia, Myelomonocytic, Chronic 10Multiple Myeloma 6Lymphoma 6Leukemia, Myelomonocytic, Juvenile 6Leukemia, Lymphocytic, Chronic, B-Cell 6Leukemia, Myeloid, Accelerated Phase 5Congenital Abnormalities 5Anemia, Refractory, with Excess of Blasts 5Recurrence 4Leukemia, Biphenotypic, Acute 4Blast Crisis 4Primary Myelofibrosis 3Neoplasms 3Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Promyelocytic, Acute 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Hematologic Neoplasms 3Graft vs Host Disease 3Lymphoma, Mantle-Cell 2

Interventions

Therapeutics 6Flow Cytometry 5Psychiatric Rehabilitation 3Immunologic Techniques 3Cyclophosphamide 3Amplified Fragment Length Polymorphism Analysis 3ruxolitinib 2pembrolizumab 2liposomal amphotericin B 2abiraterone 2Vorinostat 2Sirolimus 2Radiotherapy 2Polymerase Chain Reaction 2Ondansetron 2Mycophenolic Acid 2Methylprednisolone 2Itraconazole 2Ipilimumab 2Immunoglobulin G 2Immunoenzyme Techniques 2Gemcitabine 2Doxorubicin 2Disulfides 2Dexamethasone 2Deferasirox 2Caspofungin 2Calcium Dobesilate 2CTLA-4 Antigen 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Clofarabine × Myeloid × Clear all
NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡